Cancer Therapy

Biography

Biography: J A Garcia Urbina

Abstract

Cancer in early phase without adverse side eff ects is the expected target in the world. Th e cancer originates in glandular system produces various organ dysfunctions, and in metastases loss of life in a short time, public health problem of great social and economic importance. Carbohydrate -C40H56- Hydro-soluble Carotene (HC) identifi ed as lycopene food used in this protocol is safe and complete solubility in water diff uses into the tissues where it is more benign and remarkable eff ect early tumor suppression than any other treatment except in stomach cancer, suppresses associated neuropathy, without adverse side eff ects, and glandular system activates. HC administered in the diet at doses of 70±2, 140±4, 200±4 and 270±2mg, depending on the stage I, II, III and IV cancer, every 8 hours according to protocol and algorithm: T = D / V. Where T is the time in days of treatment the tumor, D is the maximum distance in mm from one point to another tumor, V is the average velocity (1mm/day) referral to tumor suppression. If the tumor size is 80x60x40 mm (the maximum distance D from one point to another of the tumor is 80 mm), time to tumor treatment T will be 80 days: T = 80 mm /1 mm /day = 80 days. From this it follows that T=D. In conclusion, the repeated fi nding referral to prompt suppression of the tumor with HC makes me think, cancer and other degenerative cellular alterations of glandular origin result from ancestral carotene defi ciency in the diet, by suppression under suffi cient dosage.